Literature DB >> 12069756

Regulation of ryanodine receptors via macromolecular complexes: a novel role for leucine/isoleucine zippers.

Andrew R Marks1, Steven O Marx, Steven Reiken.   

Abstract

Defective calcium (Ca(2+)) signaling, manifest as a loss of excitation-contraction (EC) coupling gain in cardiac muscle, likely plays an important role in the pathophysiology of human heart failure. The mechanism underlying this loss of cardiac EC coupling gain involves altered regulation of the cardiac ryanodine receptor (RyR2), the major sarcoplasmic reticulum Ca(2+) release channel in the heart. This altered regulation of RyR2 is due, in part, to hyperphosphorylation of the channel by cyclic adenosine monophosphate-dependent protein kinase A (PKA). PKA phosphorylation of RyR2 is controlled by a macromolecular signaling complex that targets PKA and two phosphatases (PP1 and PP2A) to the channel. The targeting of PKA, PP1, and PP2A to RyR2 is dependent on the binding of targeting proteins to the channel via highly conserved leucine/isoleucine zippers (LIZs). Formation of an ion channel macromolecular signaling complex is a novel role of LIZs. Recognition of this new function for LIZ motifs has provided a road map for rapidly identifying components of the RyR2 macromolecular signaling complex that play a key role in regulating normal cardiac physiology as part of the "fight or flight" response. The components of the RyR2 macromolecular signaling complex are also novel targets for heart failure and cardiac arrhythmia therapeutics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069756     DOI: 10.1016/s1050-1738(02)00156-1

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  24 in total

Review 1.  Defective cardiac ion channels: from mutations to clinical syndromes.

Authors:  Colleen E Clancy; Robert S Kass
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 2.  Altered intracellular Ca2+ handling in heart failure.

Authors:  Masafumi Yano; Yasuhiro Ikeda; Masunori Matsuzaki
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 3.  Calcium biology of the transverse tubules in heart.

Authors:  Long-Sheng Song; Silvia Guatimosim; Leticia Gómez-Viquez; Eric A Sobie; Andrew Ziman; Hali Hartmann; W J Lederer
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 4.  Ryanodine receptor structure: progress and challenges.

Authors:  Susan L Hamilton; Irina I Serysheva
Journal:  J Biol Chem       Date:  2008-10-16       Impact factor: 5.157

Review 5.  Intracellular calcium release channels: an update.

Authors:  Gaetano Santulli; Ryutaro Nakashima; Qi Yuan; Andrew R Marks
Journal:  J Physiol       Date:  2017-05-15       Impact factor: 5.182

Review 6.  Regulation of sarcoplasmic reticulum Ca2+ release by serine-threonine phosphatases in the heart.

Authors:  Dmitry Terentyev; Shanna Hamilton
Journal:  J Mol Cell Cardiol       Date:  2016-08-29       Impact factor: 5.000

7.  Essential Role of Calmodulin in RyR Inhibition by Dantrolene.

Authors:  Ye Win Oo; Nieves Gomez-Hurtado; Kafa Walweel; Dirk F van Helden; Mohammad S Imtiaz; Bjorn C Knollmann; Derek R Laver
Journal:  Mol Pharmacol       Date:  2015-04-28       Impact factor: 4.436

Review 8.  Minding the calcium store: Ryanodine receptor activation as a convergent mechanism of PCB toxicity.

Authors:  Isaac N Pessah; Gennady Cherednichenko; Pamela J Lein
Journal:  Pharmacol Ther       Date:  2009-11-25       Impact factor: 12.310

Review 9.  Posttranslational modifications of cardiac ryanodine receptors: Ca(2+) signaling and EC-coupling.

Authors:  Ernst Niggli; Nina D Ullrich; Daniel Gutierrez; Sergii Kyrychenko; Eva Poláková; Natalia Shirokova
Journal:  Biochim Biophys Acta       Date:  2012-08-31

10.  In situ modulation of the human cardiac ryanodine receptor (hRyR2) by FKBP12.6.

Authors:  Christopher H George; Rina Sorathia; Benedicte M A Bertrand; F Anthony Lai
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.